 | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
| Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
Insider Trading - Eloxx Pharmaceuticals Inc. (ELOX)
| | "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2019-06-24 Purchase | 2019-06-26 4:44 pm | Eloxx Pharmaceuticals Inc. | ELOX | Pontifax Management 4 G.P. (2015) Ltd. Pontifax (China) IV L.P. Pontifax (Cayman) IV L.P. Pontifax (Israel) IV L.P. Pontifax IV GP L.P. 10% Owner | 200,000 | $9 | $1,800,000 | 24,000 (Indirect) | View |
| 2019-06-24 Purchase | 2019-06-26 4:48 pm | Eloxx Pharmaceuticals Inc. | ELOX | Kariv Tomer Director | 200,000 | $9 | $1,800,000 | 24,000 (Indirect) | View |
| 2019-06-24 Purchase | 2019-06-26 4:51 pm | Eloxx Pharmaceuticals Inc. | ELOX | Nussbaum Ran Director | 200,000 | $9 | $1,800,000 | 24,000 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2019-05-29 Option Award | 2019-05-29 5:13 pm | N/A 2029-05-29 | Eloxx Pharmaceuticals Inc. | ELOX | Kariv Tomer Director | 20,000 | $9.02 | 20,000 (Direct) | View |
| 2019-05-29 Option Award | 2019-05-29 5:15 pm | N/A 2029-05-29 | Eloxx Pharmaceuticals Inc. | ELOX | Pontifax Management 4 G.P. (2015) Ltd. Pontifax IV GP L.P. Pontifax (Cayman) IV L.P. Pontifax (China) IV L.P. Pontifax (Israel) IV L.P. Pontifax Management III G.P. (2011) Ltd. Pontifax Management Fund III L.P. Pontifax (Cayman) III L.P. Pontifax (Israel) III L.P. 10% Owner | 20,000 | $9.02 | 20,000 (Indirect) | View |
| 2019-05-29 Option Award | 2019-05-29 5:15 pm | N/A 2029-05-29 | Eloxx Pharmaceuticals Inc. | ELOX | Pontifax Management 4 G.P. (2015) Ltd. Pontifax IV GP L.P. Pontifax (Cayman) IV L.P. Pontifax (China) IV L.P. Pontifax (Israel) IV L.P. Pontifax Management III G.P. (2011) Ltd. Pontifax Management Fund III L.P. Pontifax (Cayman) III L.P. Pontifax (Israel) III L.P. 10% Owner | 20,000 | $9.02 | 20,000 (Indirect) | View |
| 2019-05-29 Option Award | 2019-05-29 5:17 pm | N/A 2029-05-29 | Eloxx Pharmaceuticals Inc. | ELOX | Avnur Zafrira Director | 20,000 | $9.02 | 20,000 (Direct) | View |
| 2019-05-29 Option Award | 2019-05-29 5:21 pm | N/A 2029-05-29 | Eloxx Pharmaceuticals Inc. | ELOX | Nussbaum Ran Director | 20,000 | $9.02 | 20,000 (Direct) | View |
| 2019-05-29 Option Award | 2019-05-29 5:22 pm | N/A 2029-05-29 | Eloxx Pharmaceuticals Inc. | ELOX | Noiman Silvia Director | 20,000 | $9.02 | 20,000 (Direct) | View |
| 2019-05-29 Option Award | 2019-05-30 2:06 pm | N/A 2029-05-29 | Eloxx Pharmaceuticals Inc. | ELOX | Kleijwegt Martijn Director | 20,000 | $9.02 | 20,000 (Direct) | View |
| 2019-05-29 Option Award | 2019-05-30 3:45 pm | N/A 2029-05-29 | Eloxx Pharmaceuticals Inc. | ELOX | Nussbaum Ran Director | 20,000 | $9.02 | 20,000 (Direct) | View |
| 2019-06-26 Exercise | 2019-06-27 5:39 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Ward Robert CEO | 35,599 | $0 | 355,992 (Direct) | View |
| 2019-06-26 Tax Withholding | 2019-06-27 5:39 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Ward Robert CEO | 10,467 | $9.03 | 355,992 (Direct) | View |
| 2019-06-26 Exercise | 2019-06-27 5:39 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Ward Robert CEO | 35,599 | $0 | 355,992 (Direct) | View |
| 2019-09-12 Option Award | 2019-09-13 4:10 pm | N/A 2029-09-12 | Eloxx Pharmaceuticals Inc. | ELOX | Williams Gregory C. COO | 225,000 | $6.47 | 225,000 (Direct) | View |
| 2019-09-12 Option Award | 2019-09-13 4:10 pm | N/A 2029-09-12 | Eloxx Pharmaceuticals Inc. | ELOX | Belloff Neil S. GENERAL COUNSEL/CORPORATE SECR | 100,000 | $6.47 | 100,000 (Direct) | View |
| 2019-09-12 Option Award | 2019-09-13 4:10 pm | N/A 2029-09-12 | Eloxx Pharmaceuticals Inc. | ELOX | Snow David P. CHIEF BUSINESS OFFICER | 150,000 | $6.47 | 150,000 (Direct) | View |
| 2019-09-26 Exercise | 2019-09-27 4:10 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Ward Robert CEO Chairman | 35,599 | $0 | 320,393 (Direct) | View |
| 2019-09-26 Tax Withholding | 2019-09-27 4:10 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Ward Robert CEO Chairman | 10,467 | $4.37 | 320,393 (Direct) | View |
| 2019-09-26 Exercise | 2019-09-27 4:10 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Ward Robert CEO Chairman | 35,599 | $0 | 320,393 (Direct) | View |
| 2019-12-26 Exercise | 2019-12-27 4:10 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Ward Robert CEO Chairman | 35,599 | $0 | 284,794 (Direct) | View |
| 2019-12-26 Tax Withholding | 2019-12-27 4:10 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Ward Robert CEO Chairman | 15,806 | $7.26 | 284,794 (Direct) | View |
| 2019-12-26 Exercise | 2019-12-27 4:10 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Ward Robert CEO Chairman | 35,599 | $0 | 284,794 (Direct) | View |
| 2020-01-30 Exercise | 2020-01-31 5:15 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Belloff Neil S. GENERAL COUNSEL/CORPORATE SECR | 6,250 | $0 | 18,750 (Direct) | View |
| 2020-01-30 Tax Withholding | 2020-01-31 5:15 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Belloff Neil S. GENERAL COUNSEL/CORPORATE SECR | 2,166 | $3.91 | 18,750 (Direct) | View |
| 2020-01-30 Exercise | 2020-01-31 5:15 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Belloff Neil S. GENERAL COUNSEL/CORPORATE SECR | 6,250 | $0 | 18,750 (Direct) | View |
| 2020-01-30 Exercise | 2020-01-31 5:15 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Snow David P. CHIEF BUSINESS OFFICER | 6,250 | $0 | 18,750 (Direct) | View |
| 2020-01-30 Tax Withholding | 2020-01-31 5:15 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Snow David P. CHIEF BUSINESS OFFICER | 2,045 | $3.91 | 18,750 (Direct) | View |
| 2020-01-30 Exercise | 2020-01-31 5:15 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Snow David P. CHIEF BUSINESS OFFICER | 6,250 | $0 | 18,750 (Direct) | View |
| 2020-01-30 Exercise | 2020-01-31 5:15 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Williams Gregory C. COO | 7,500 | $0 | 22,500 (Direct) | View |
| 2020-01-30 Tax Withholding | 2020-01-31 5:15 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Williams Gregory C. COO | 2,590 | $3.91 | 22,500 (Direct) | View |
| 2020-01-30 Exercise | 2020-01-31 5:15 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Williams Gregory C. COO | 7,500 | $0 | 22,500 (Direct) | View |
| 2020-01-30 Exercise | 2020-01-31 5:26 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | WEAVER GREGORY L CFO | 5,000 | $0 | 15,000 (Direct) | View |
| 2020-01-30 Tax Withholding | 2020-01-31 5:26 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | WEAVER GREGORY L CFO | 1,733 | $3.91 | 15,000 (Direct) | View |
| 2020-01-30 Exercise | 2020-01-31 5:26 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | WEAVER GREGORY L CFO | 5,000 | $0 | 15,000 (Direct) | View |
| 2020-02-25 Option Award | 2020-02-26 7:01 pm | N/A 2030-02-25 | Eloxx Pharmaceuticals Inc. | ELOX | Belloff Neil S. COO | 200,000 | $3.59 | 100,000 (Direct) | View |
| 2020-02-25 Option Award | 2020-02-26 7:01 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Belloff Neil S. COO | 100,000 | $0 | 100,000 (Direct) | View |
| 2020-02-25 Option Award | 2020-02-26 7:03 pm | N/A 2030-02-25 | Eloxx Pharmaceuticals Inc. | ELOX | Williams Gregory C. CEO | 400,000 | $3.59 | 200,000 (Direct) | View |
| 2020-02-25 Option Award | 2020-02-26 7:03 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Williams Gregory C. CEO | 200,000 | $0 | 200,000 (Direct) | View |
| 2020-02-29 Exercise | 2020-03-03 6:30 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Ward Robert CEO Chairman | 76,806 | $0 | 0 (Direct) | View |
| 2020-02-29 Tax Withholding | 2020-03-03 6:30 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Ward Robert CEO Chairman | 23,285 | $3.13 | 0 (Direct) | View |
| 2020-02-29 Exercise | 2020-03-03 6:30 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Ward Robert CEO Chairman | 71,199 | $0 | 0 (Direct) | View |
| 2020-02-29 Exercise | 2020-03-03 6:30 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Ward Robert CEO Chairman | 5,607 | $0 | 0 (Direct) | View |
| 2020-02-29 Exercise | 2020-03-03 6:30 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Snow David P. FORMER CHIEF BUSINESS OFFICER | 4,688 | $0 | 0 (Direct) | View |
| 2020-02-29 Tax Withholding | 2020-03-03 6:30 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Snow David P. FORMER CHIEF BUSINESS OFFICER | 1,534 | $3.13 | 0 (Direct) | View |
| 2020-02-29 Exercise | 2020-03-03 6:30 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Snow David P. FORMER CHIEF BUSINESS OFFICER | 4,688 | $0 | 0 (Direct) | View |
| 2020-01-30 Exercise | 2020-03-04 2:30 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | WEAVER GREGORY L CFO | 5,000 | $0 | 15,000 (Direct) | View |
| 2020-01-30 Tax Withholding | 2020-03-04 2:30 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | WEAVER GREGORY L CFO | 1,733 | $3.91 | 15,000 (Direct) | View |
| 2020-01-30 Exercise | 2020-03-04 2:30 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | WEAVER GREGORY L CFO | 5,000 | $0 | 15,000 (Direct) | View |
| 2020-01-30 Exercise | 2020-03-04 2:30 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Williams Gregory C. CEO | 7,500 | $0 | 22,500 (Direct) | View |
| 2020-01-30 Tax Withholding | 2020-03-04 2:30 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Williams Gregory C. CEO | 2,590 | $3.91 | 22,500 (Direct) | View |
| 2020-01-30 Exercise | 2020-03-04 2:30 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Williams Gregory C. CEO | 7,500 | $0 | 22,500 (Direct) | View |
| 2020-01-30 Exercise | 2020-03-04 2:30 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Snow David P. FORMER CHIEF BUSINESS OFFICER | 6,250 | $0 | 18,750 (Direct) | View |
| 2020-01-30 Tax Withholding | 2020-03-04 2:30 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Snow David P. FORMER CHIEF BUSINESS OFFICER | 2,045 | $3.91 | 18,750 (Direct) | View |
| 2020-01-30 Exercise | 2020-03-04 2:30 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Snow David P. FORMER CHIEF BUSINESS OFFICER | 6,250 | $0 | 18,750 (Direct) | View |
| 2020-01-30 Exercise | 2020-03-04 2:30 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Belloff Neil S. COO | 6,250 | $0 | 18,750 (Direct) | View |
| 2020-01-30 Tax Withholding | 2020-03-04 2:30 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Belloff Neil S. COO | 2,166 | $3.91 | 18,750 (Direct) | View |
| 2020-01-30 Exercise | 2020-03-04 2:30 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Belloff Neil S. COO | 6,250 | $0 | 18,750 (Direct) | View |
| 2020-03-15 Exercise | 2020-03-16 4:10 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | WEAVER GREGORY L CFO | 3,750 | $0 | 0 (Direct) | View |
| 2020-03-15 Tax Withholding | 2020-03-16 4:10 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | WEAVER GREGORY L CFO | 1,086 | $2.85 | 0 (Direct) | View |
| 2020-03-15 Exercise | 2020-03-16 4:10 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | WEAVER GREGORY L CFO | 3,750 | $0 | 0 (Direct) | View |
| 2020-04-30 Exercise | 2020-05-01 5:20 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Belloff Neil S. COO | 1,562 | $0 | 17,188 (Direct) | View |
| 2020-04-30 Tax Withholding | 2020-05-01 5:20 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Belloff Neil S. COO | 459 | $2.92 | 17,188 (Direct) | View |
| 2020-04-30 Exercise | 2020-05-01 5:20 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Belloff Neil S. COO | 1,562 | $0 | 17,188 (Direct) | View |
| 2020-04-30 Exercise | 2020-05-01 5:20 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Williams Gregory C. CEO | 1,875 | $0 | 20,625 (Direct) | View |
| 2020-04-30 Tax Withholding | 2020-05-01 5:20 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Williams Gregory C. CEO | 577 | $2.92 | 20,625 (Direct) | View |
| 2020-04-30 Exercise | 2020-05-01 5:20 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | Williams Gregory C. CEO | 1,875 | $0 | 20,625 (Direct) | View |
| 2020-05-20 Option Award | 2020-05-22 4:10 pm | N/A 2030-05-20 | Eloxx Pharmaceuticals Inc. | ELOX | Kleijwegt Martijn Director | 20,000 | $3.39 | 20,000 (Direct) | View |
| 2020-05-20 Option Award | 2020-05-22 4:10 pm | N/A 2030-05-20 | Eloxx Pharmaceuticals Inc. | ELOX | Nussbaum Ran Director | 20,000 | $3.39 | 20,000 (Direct) | View |
| 2020-05-20 Option Award | 2020-05-22 4:10 pm | N/A 2030-05-20 | Eloxx Pharmaceuticals Inc. | ELOX | Noiman Silvia Director | 20,000 | $3.39 | 20,000 (Direct) | View |
| 2020-05-20 Option Award | 2020-05-22 4:10 pm | N/A 2030-05-20 | Eloxx Pharmaceuticals Inc. | ELOX | Avnur Zafrira Director | 20,000 | $3.39 | 20,000 (Direct) | View |
| 2020-05-20 Option Award | 2020-05-22 4:10 pm | N/A 2030-05-20 | Eloxx Pharmaceuticals Inc. | ELOX | Kariv Tomer Director | 20,000 | $3.39 | 20,000 (Direct) | View |
| 2020-05-20 Option Award | 2020-05-22 4:10 pm | N/A 2030-05-20 | Eloxx Pharmaceuticals Inc. | ELOX | Veinrib Gadi Director | 20,000 | $3.39 | 20,000 (Direct) | View |
| 2020-05-20 Option Award | 2020-05-22 4:10 pm | N/A 2030-05-20 | Eloxx Pharmaceuticals Inc. | ELOX | Seehra Jasbir Director | 20,000 | $3.39 | 20,000 (Direct) | View |
| 2020-05-20 Option Award | 2020-05-22 4:10 pm | N/A 2030-05-20 | Eloxx Pharmaceuticals Inc. | ELOX | Pontifax Management 4 G.P. (2015) Ltd. Pontifax IV GP L.P. Pontifax (Cayman) IV L.P. Pontifax (China) IV L.P. Pontifax (Israel) IV L.P. Pontifax Management III G.P. (2011) Ltd. Pontifax Management Fund III L.P. Pontifax (Cayman) III L.P. Pontifax (Israel) III L.P. 10% Owner | 20,000 | $3.39 | 20,000 (Indirect) | View |
| 2020-05-20 Option Award | 2020-05-22 4:10 pm | N/A 2030-05-20 | Eloxx Pharmaceuticals Inc. | ELOX | Pontifax Management 4 G.P. (2015) Ltd. Pontifax IV GP L.P. Pontifax (Cayman) IV L.P. Pontifax (China) IV L.P. Pontifax (Israel) IV L.P. Pontifax Management III G.P. (2011) Ltd. Pontifax Management Fund III L.P. Pontifax (Cayman) III L.P. Pontifax (Israel) III L.P. 10% Owner | 20,000 | $3.39 | 20,000 (Indirect) | View |
| 2020-05-20 Option Award | 2020-05-26 3:03 pm | N/A 2030-05-20 | Eloxx Pharmaceuticals Inc. | ELOX | Rubin Steven D Director | 20,000 | $3.39 | 20,000 (Direct) | View |